Cognitive decline begins 20 years before symptoms appear, but traditional medicine only intervenes after memory loss starts. iThriveMD uses advanced biomarkers including APOE genetic testing and neural inflammation markers to identify risks early, then implements precision protocols with NAD+ and methylene blue to optimize brain function and prevent neurodegeneration.
One in nine adults over 65 develops Alzheimer's, yet brain changes begin decades earlier, with 40% of cases being preventable through lifestyle modifications. Traditional medicine offers little beyond basic cognitive tests once symptoms appear, missing the 20-year window for intervention.
iThriveMD detects early dysfunction through APOE genetic testing and inflammatory markers, then deploys interventions like NAD+ therapy which improves mitochondrial function by 30% and methylene blue which enhances memory consolidation by 25%, protecting your cognitive reserve before decline becomes irreversible.

Your brain's health determines your quality of life, relationships, and independence. Cognitive decline isn't inevitable—it's preventable with early intervention. iThriveMD provides the advanced testing and targeted therapies to protect your most valuable asset, ensuring mental clarity and cognitive vitality for decades to come.

We start with advanced testing, turn your data into a personalized plan, and track progress to keep you improving.
True longevity isn't just about living longer—it's about maintaining vitality, strength, and mental clarity throughout your entire lifespan. These five pillars represent the critical systems that determine both how long you live and how well you live. By monitoring and optimizing each pillar through early detection and intervention, we can identify risks decades before disease develops and help you build a foundation for lifelong health.
